Showing results (171-180 of 201) with videos related to
Sort By:
Pageof 21
Nature Communications|November 12, 2025
A non-canonical lymphoblast in refractory childhood T-cell leukaemiaBram S J Lim, Holly J Whitfield, Mi K Trinh, et al.Oncogene|November 28, 2018
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemiaKaren A Urtishak, Li-San Wang, Biljana Culjkovic-Kraljacic, et al.Blood Advances|December 8, 2020
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentationsCaroline Diorio, Kevin O McNerney, Michele Lambert, et al.Journal for Immunotherapy of Cancer|December 18, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse eventsMarcela V Maus, Sara Alexander, Michael R Bishop, et al.Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Dysregulated STAT3 signaling and T cell immunometabolic dysfunction define a targetable, high mortality subphenotype of critically ill childrenRobert B Lindell, Samir Sayed, Jose S Campos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2021
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaRegina M Myers, Yimei Li, Allison Barz Leahy, et al.The Journal of Experimental Medicine|November 9, 2018
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemiaIngrid M Ariës, Kimberly Bodaar, Salmaan A Karim, et al.Cancer Medicine|April 4, 2024
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity researchHaley Newman, Yimei Li, Yuan-Shung V Huang, et al.Pediatric Blood & Cancer|September 5, 2020
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndromeCaroline Diorio, Elizabeth M Anderson, Kevin O McNerney, et al.The Journal of Clinical Investigation|October 23, 2025
The hematopoietic stem cell MYB enhancer is essential for and recurrently amplified during T cell leukemogenesisCarea Mullin, Karena Lin, Elizabeth Choe, et al.Pageof 21